Global Drug Eluting Beads Market Research Report 2019
Table of Contents
Executive Summary
1 Drug Eluting Beads Market Overview
- 1.1 Product Overview and Scope of Drug Eluting Beads
- 1.2 Drug Eluting Beads Segment by Type
- 1.2.1 Global Drug Eluting Beads Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Oncozene Beads
- 1.2.3 Quadra Sphere
- 1.2.4 LC Beads
- 1.2.5 Others
- 1.3 Drug Eluting Beads Segment by Application
- 1.3.1 Drug Eluting Beads Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Specialized Clinics
- 1.3.4 Research Centers
- 1.3.5 Ambulatory Surgical Centers
- 1.4 Global Drug Eluting Beads Market by Region
- 1.4.1 Global Drug Eluting Beads Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Drug Eluting Beads Market Size
- 1.5.1 Global Drug Eluting Beads Revenue (2014-2025)
- 1.5.2 Global Drug Eluting Beads Production (2014-2025)
2 Global Drug Eluting Beads Market Competition by Manufacturers
- 2.1 Global Drug Eluting Beads Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Drug Eluting Beads Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Drug Eluting Beads Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Drug Eluting Beads Production Sites, Area Served, Product Types
- 2.5 Drug Eluting Beads Market Competitive Situation and Trends
- 2.5.1 Drug Eluting Beads Market Concentration Rate
- 2.5.2 Drug Eluting Beads Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Drug Eluting Beads Production Market Share by Regions
- 3.1 Global Drug Eluting Beads Production Market Share by Regions
- 3.2 Global Drug Eluting Beads Revenue Market Share by Regions (2014-2019)
- 3.3 Global Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Drug Eluting Beads Production
- 3.4.1 North America Drug Eluting Beads Production Growth Rate (2014-2019)
- 3.4.2 North America Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Drug Eluting Beads Production
- 3.5.1 Europe Drug Eluting Beads Production Growth Rate (2014-2019)
- 3.5.2 Europe Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Drug Eluting Beads Production (2014-2019)
- 3.6.1 China Drug Eluting Beads Production Growth Rate (2014-2019)
- 3.6.2 China Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Drug Eluting Beads Production (2014-2019)
- 3.7.1 Japan Drug Eluting Beads Production Growth Rate (2014-2019)
- 3.7.2 Japan Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Drug Eluting Beads Consumption by Regions
- 4.1 Global Drug Eluting Beads Consumption by Regions
- 4.2 North America Drug Eluting Beads Consumption (2014-2019)
- 4.3 Europe Drug Eluting Beads Consumption (2014-2019)
- 4.4 China Drug Eluting Beads Consumption (2014-2019)
- 4.5 Japan Drug Eluting Beads Consumption (2014-2019)
5 Global Drug Eluting Beads Production, Revenue, Price Trend by Type
- 5.1 Global Drug Eluting Beads Production Market Share by Type (2014-2019)
- 5.2 Global Drug Eluting Beads Revenue Market Share by Type (2014-2019)
- 5.3 Global Drug Eluting Beads Price by Type (2014-2019)
- 5.4 Global Drug Eluting Beads Production Growth by Type (2014-2019)
6 Global Drug Eluting Beads Market Analysis by Applications
- 6.1 Global Drug Eluting Beads Consumption Market Share by Application (2014-2019)
- 6.2 Global Drug Eluting Beads Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Drug Eluting Beads Business
- 7.1 Biocompatibles
- 7.1.1 Biocompatibles Drug Eluting Beads Production Sites and Area Served
- 7.1.2 Drug Eluting Beads Product Introduction, Application and Specification
- 7.1.3 Biocompatibles Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 BTG International
- 7.2.1 BTG International Drug Eluting Beads Production Sites and Area Served
- 7.2.2 Drug Eluting Beads Product Introduction, Application and Specification
- 7.2.3 BTG International Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Merit Medical Systems
- 7.3.1 Merit Medical Systems Drug Eluting Beads Production Sites and Area Served
- 7.3.2 Drug Eluting Beads Product Introduction, Application and Specification
- 7.3.3 Merit Medical Systems Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 CeloNova BioSciences
- 7.4.1 CeloNova BioSciences Drug Eluting Beads Production Sites and Area Served
- 7.4.2 Drug Eluting Beads Product Introduction, Application and Specification
- 7.4.3 CeloNova BioSciences Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 ABK Biomedical
- 7.5.1 ABK Biomedical Drug Eluting Beads Production Sites and Area Served
- 7.5.2 Drug Eluting Beads Product Introduction, Application and Specification
- 7.5.3 ABK Biomedical Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Boston Scientific
- 7.6.1 Boston Scientific Drug Eluting Beads Production Sites and Area Served
- 7.6.2 Drug Eluting Beads Product Introduction, Application and Specification
- 7.6.3 Boston Scientific Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Medtronic
- 7.7.1 Medtronic Drug Eluting Beads Production Sites and Area Served
- 7.7.2 Drug Eluting Beads Product Introduction, Application and Specification
- 7.7.3 Medtronic Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Merit Medical Systems
- 7.8.1 Merit Medical Systems Drug Eluting Beads Production Sites and Area Served
- 7.8.2 Drug Eluting Beads Product Introduction, Application and Specification
- 7.8.3 Merit Medical Systems Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Surefire Medical
- 7.9.1 Surefire Medical Drug Eluting Beads Production Sites and Area Served
- 7.9.2 Drug Eluting Beads Product Introduction, Application and Specification
- 7.9.3 Surefire Medical Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Terumo
- 7.10.1 Terumo Drug Eluting Beads Production Sites and Area Served
- 7.10.2 Drug Eluting Beads Product Introduction, Application and Specification
- 7.10.3 Terumo Drug Eluting Beads Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
8 Drug Eluting Beads Manufacturing Cost Analysis
- 8.1 Drug Eluting Beads Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Drug Eluting Beads
- 8.4 Drug Eluting Beads Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Drug Eluting Beads Distributors List
- 9.3 Drug Eluting Beads Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Drug Eluting Beads Market Forecast
- 11.1 Global Drug Eluting Beads Production, Revenue Forecast
- 11.1.1 Global Drug Eluting Beads Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Drug Eluting Beads Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Drug Eluting Beads Price and Trend Forecast (2019-2025)
- 11.2 Global Drug Eluting Beads Production Forecast by Regions (2019-2025)
- 11.2.1 North America Drug Eluting Beads Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Drug Eluting Beads Production, Revenue Forecast (2019-2025)
- 11.2.3 China Drug Eluting Beads Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Drug Eluting Beads Production, Revenue Forecast (2019-2025)
- 11.3 Global Drug Eluting Beads Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Drug Eluting Beads Consumption Forecast (2019-2025)
- 11.3.2 Europe Drug Eluting Beads Consumption Forecast (2019-2025)
- 11.3.3 China Drug Eluting Beads Consumption Forecast (2019-2025)
- 11.3.4 Japan Drug Eluting Beads Consumption Forecast (2019-2025)
- 11.4 Global Drug Eluting Beads Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Drug Eluting Beads Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
The global drug eluting beads market is primarily driven by the increasing prevalence of liver diseases. Increasing awareness among people regarding the benefits of drug eluting beads therapy is also expected to drive the growth of the global drug eluting beads market. However, lack of skilled physicians is expected to restrain the market growth.
The global Drug Eluting Beads market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Drug Eluting Beads volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drug Eluting Beads market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Biocompatibles
BTG International
Merit Medical Systems
CeloNova BioSciences
ABK Biomedical
Boston Scientific
Medtronic
Merit Medical Systems
Surefire Medical
Terumo
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Oncozene Beads
Quadra Sphere
LC Beads
Others
Segment by Application
Hospitals
Specialized Clinics
Research Centers
Ambulatory Surgical Centers